FDA Adverse Event Malfunction Summary report: N

LS PRI PLUM 15 MICRON CL 0.2M PE 272CM

MDR report key: 8784760 · Received July 12, 2019

Report

Report Number
9615050-2019-00248
Event Type
Malfunction
Date Received
July 12, 2019
Date of Event
June 17, 2019
Report Date
June 18, 2019
Manufacturer
ICU MEDICAL COSTA RICA LTD.
Product Code
FPA
PMA / PMN Number
K141789
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
HK
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

THE REPORTED CRACKED MALE LUER WAS CONFIRMED BY INVESTIGATION. NO PRODUCT SAMPLES WERE RETURNED FOR INVESTIGATION. THE CUSTOMER PROVIDED SEVERAL PICTURES DOCUMENTING THE REPORTED SET WITH BROKEN MALE LUER TIP. THE TIP OF THE MALE LUER WAS STUCK INSIDE THE MATING DEVICE. WITHOUT THE RETURN OF THE PRODUCT A COMPREHENSIVE FAILURE INVESTIGATION CANNOT BE PERFORMED AND A CAUSE CANNOT BE DETERMINED. THE LOT REVIEW WAS PERFORMED WITH NO ISSUES NOTED.

Additional Manufacturer Narrative · 1

THE DEVICE IS NOT AVAILABLE FOR EVALUATION. IF ADDITIONAL INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT A PLUM SET WAS DAMAGED WITH TIP OF THE LUER DETACHED AND LEFT INSIDE THE INNER LUMEN OF PATIENT'S PICC FEMALE LUER CONNECTOR. THE PATIENT WAS BEING PREPPED FOR CHEMOTHERAPY (DOXORUBICIN 20MG + ETOPOSIDE 90MG + VINCRISTINE SULPHATE 0.8MG IN 1000 ML 0.9% NACL). THE NURSE FOUND IT DIFFICULT TO REMOVE THE PLUM SET MALE LUER ADAPTOR FROM PICC FEMALE LUER CONNECTOR. WHEN THE SET WAS REMOVED, THE MALE LUER TIP WAS DETACHED AND LEFT IN THE INNER LUMEN OF PICC FEMALE LUER. A SURGERY WAS ARRANGED FOR THE PATIENT TO REPLACE THE PICC. THERE WAS PATIENT INVOLVEMENT, BUT NO REPORT OF AN ADVERSE EVENT OR DELAY IN CRITICAL THERAPY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
579157 LS PRI PLUM 15 MICRON CL 0.2M PE 272CM SET, ADMINISTRATION, INTRAVASCULAR FPA ICU MEDICAL COSTA RICA LTD. 810635H

Patients

Seq Age Sex Outcome Treatment
1 DOXORUBICIN| ETOPOSIDE| NACL| VINCRISTINE SULPHATE| DOXORUBICIN| ETOPOSIDE| NACL| VINCRISTINE SULPHATE